 Leading drug manufacturer Beximco Pharmaceuticals Ltd. (BPL) on September 13 donated 5000 pieces of Oseflu (Oseltamivir) capsule to ICDDR,B as a gesture of BPL's support for the swine flu affected community of the country.
This donation was a part of BPL's ongoing CSR activities as a response to this major public health problem.
Beximco Pharma is the pioneer in introducing Oseltamivir preparation is Bangladesh. Back in March 22, 2006, Beximco Pharma introduced Oseflu capsule for the prevention and treatment of human cases of Avian Influenza (H5N1).
Besides its use in Bangladesh, Beximco Pharma also supplied Oseflu in ASEAN countries, Central America and Latin America for the treatment of Swine flu affected people.
Beximco Pharma has also started a public awareness programme against swine flu which comprises public awareness posters, inserts, patient information guide, sticker and advertisement in the newspaper.
Regarding the donation of the drug, the Beximco Pharma's Managing Director, Nazmul Hassan, MP, said, "Beximco Pharma always likes to work together with reputed organizations like ICDDR,B in public health related issues.
Bangladesh is under great threat of facing consequences of Swine Flu and it's everyone's combined effort that can create a strong resistance against this deadly disease in Bangladesh."
Dr. Mark Pietroni, Medical Director of ICDDR,B also spoke on the occasion of handing over the medicine and said, "We welcome this nice gesture of Beximco Pharma that would be of great help for patients coming to us for the treatment of Swine Flu".
As a part of its public awareness programme, the company has also opened a '24 hour Swine flu Hotline (01711-438-139)' for all to provide information on Swine Flu and its management. |